ROYAL BANK OF CANADA - KAZIA THERAPEUTICS LTD ownership

KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 14 filers reported holding KAZIA THERAPEUTICS LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of KAZIA THERAPEUTICS LTD
ValueSharesWeighting
Q2 2022$4,000
-50.0%
1,0000.0%0.00%
Q1 2022$8,000
+700.0%
1,000
+1751.9%
0.00%
Q3 2021$1,000
-75.0%
54
-95.7%
0.00%
Q2 2018$4,000
-42.9%
1,2500.0%0.00%
Q1 2018$7,000
+75.0%
1,2500.0%0.00%
Q4 2017$4,0001,2500.00%
Other shareholders
KAZIA THERAPEUTICS LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Atom Investors LP 99,180$857,0000.09%
HighPoint Advisor Group LLC 32,435$368,0000.04%
Transform Wealth, LLC 106,245$95,0000.02%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 19,600$170,0000.00%
Renaissance Technologies 79,625$688,0000.00%
TRUIST FINANCIAL CORP 35,260$304,0000.00%
UBS Group AG 2,851$25,0000.00%
BREWIN DOLPHIN LTD 32$2760.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
WELLS FARGO & COMPANY/MN 2,800$24,0000.00%
View complete list of KAZIA THERAPEUTICS LTD shareholders